Original Research
Accepted on 01 Sep 2025
Cholesterol Metabolic Reprogramming Drives the Onset of DLBCL and Represents a Promising Therapeutic Target
in Cancer Cell Biology
- 128 views
Original Research
Accepted on 01 Sep 2025
in Cancer Cell Biology
Review
Accepted on 01 Sep 2025
in Stem Cell Research
Original Research
Accepted on 01 Sep 2025
in Clinical Infectious Diseases
Original Research
Accepted on 01 Sep 2025
in Injury Prevention and Rehabilitation
Systematic Review
Accepted on 01 Sep 2025
in Pulmonary Medicine
Review
Accepted on 01 Sep 2025
in Biomaterials
Brief Research Report
Accepted on 01 Sep 2025
in Headache and Neurogenic Pain
Original Research
Accepted on 01 Sep 2025
in Pulmonary Medicine
Original Research
Accepted on 01 Sep 2025
in Infectious Diseases: Pathogenesis and Therapy
Original Research
Accepted on 01 Sep 2025
in Robotic Control Systems
Mini Review
Accepted on 01 Sep 2025
in T Cell Biology
Editorial
Accepted on 01 Sep 2025
in Pathology
Perspective
Accepted on 01 Sep 2025
in Space Economy
Original Research
Accepted on 01 Sep 2025
in Maternal Health
Perspective
Accepted on 01 Sep 2025
in Cancer Immunity and Immunotherapy
Review
Accepted on 01 Sep 2025
in Molecular Mechanisms of Aging